rs6929274

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_032861.4(SERAC1):​c.249C>T​(p.Asp83Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.709 in 1,554,476 control chromosomes in the GnomAD database, including 393,101 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.72 ( 39245 hom., cov: 32)
Exomes 𝑓: 0.71 ( 353856 hom. )

Consequence

SERAC1
NM_032861.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.304

Publications

27 publications found
Variant links:
Genes affected
SERAC1 (HGNC:21061): (serine active site containing 1) The protein encoded by this gene is a phosphatidylglycerol remodeling protein found at the interface of mitochondria and endoplasmic reticula, where it mediates phospholipid exchange. The encoded protein plays a major role in mitochondrial function and intracellular cholesterol trafficking. Defects in this gene are a cause of 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome (MEGDEL). Two transcript variants, one protein-coding and the other non-protein coding, have been found for this gene. [provided by RefSeq, Aug 2012]
SERAC1 Gene-Disease associations (from GenCC):
  • 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, G2P, Orphanet, Labcorp Genetics (formerly Invitae)
  • Leigh syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
Variant 6-158150469-G-A is Benign according to our data. Variant chr6-158150469-G-A is described in ClinVar as Benign. ClinVar VariationId is 139093.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.304 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.788 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SERAC1NM_032861.4 linkc.249C>T p.Asp83Asp synonymous_variant Exon 4 of 17 ENST00000647468.2 NP_116250.3 Q96JX3-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SERAC1ENST00000647468.2 linkc.249C>T p.Asp83Asp synonymous_variant Exon 4 of 17 NM_032861.4 ENSP00000496731.1 Q96JX3-1

Frequencies

GnomAD3 genomes
AF:
0.717
AC:
109013
AN:
151936
Hom.:
39201
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.710
Gnomad AMI
AF:
0.659
Gnomad AMR
AF:
0.800
Gnomad ASJ
AF:
0.729
Gnomad EAS
AF:
0.733
Gnomad SAS
AF:
0.667
Gnomad FIN
AF:
0.715
Gnomad MID
AF:
0.775
Gnomad NFE
AF:
0.706
Gnomad OTH
AF:
0.720
GnomAD2 exomes
AF:
0.724
AC:
178863
AN:
247092
AF XY:
0.718
show subpopulations
Gnomad AFR exome
AF:
0.709
Gnomad AMR exome
AF:
0.848
Gnomad ASJ exome
AF:
0.736
Gnomad EAS exome
AF:
0.719
Gnomad FIN exome
AF:
0.712
Gnomad NFE exome
AF:
0.706
Gnomad OTH exome
AF:
0.718
GnomAD4 exome
AF:
0.708
AC:
993389
AN:
1402422
Hom.:
353856
Cov.:
29
AF XY:
0.707
AC XY:
495198
AN XY:
700360
show subpopulations
African (AFR)
AF:
0.707
AC:
22756
AN:
32172
American (AMR)
AF:
0.843
AC:
36815
AN:
43652
Ashkenazi Jewish (ASJ)
AF:
0.735
AC:
18818
AN:
25610
East Asian (EAS)
AF:
0.796
AC:
31353
AN:
39368
South Asian (SAS)
AF:
0.671
AC:
56236
AN:
83848
European-Finnish (FIN)
AF:
0.711
AC:
37110
AN:
52212
Middle Eastern (MID)
AF:
0.712
AC:
4017
AN:
5644
European-Non Finnish (NFE)
AF:
0.702
AC:
744829
AN:
1061500
Other (OTH)
AF:
0.710
AC:
41455
AN:
58416
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.435
Heterozygous variant carriers
0
11714
23427
35141
46854
58568
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18518
37036
55554
74072
92590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.718
AC:
109116
AN:
152054
Hom.:
39245
Cov.:
32
AF XY:
0.718
AC XY:
53390
AN XY:
74316
show subpopulations
African (AFR)
AF:
0.710
AC:
29423
AN:
41442
American (AMR)
AF:
0.800
AC:
12229
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.729
AC:
2525
AN:
3466
East Asian (EAS)
AF:
0.734
AC:
3798
AN:
5176
South Asian (SAS)
AF:
0.667
AC:
3217
AN:
4822
European-Finnish (FIN)
AF:
0.715
AC:
7543
AN:
10552
Middle Eastern (MID)
AF:
0.776
AC:
228
AN:
294
European-Non Finnish (NFE)
AF:
0.706
AC:
48035
AN:
67996
Other (OTH)
AF:
0.720
AC:
1520
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1580
3160
4741
6321
7901
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
840
1680
2520
3360
4200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.710
Hom.:
74741
Bravo
AF:
0.723
Asia WGS
AF:
0.716
AC:
2487
AN:
3476
EpiCase
AF:
0.714
EpiControl
AF:
0.715

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Sep 05, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Feb 19, 2016
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.53
CADD
Benign
6.7
DANN
Benign
0.42
PhyloP100
0.30
Mutation Taster
=84/16
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6929274; hg19: chr6-158571501; COSMIC: COSV108214273; API